NAD+

Research

Nicotinamide Adenine Dinucleotide

Aliases
Coenzyme I, NAD
Administration
IV infusion, Subcutaneous injection, Oral (as precursors NMN/NR)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Some users report feeling less fatigued and mentally sharper within days of an infusion series.

  2. 2

    3–4 Weeks

    Effects following an infusion series are commonly described as tapering unless repeated.

  3. 3

    5–7 Weeks

    Users on repeated infusion schedules often report a steadier baseline energy level.

  4. 4

    8–10 Weeks

    Continued use is commonly associated with more consistent mental clarity for regular users.

  5. 5

    11–15 Weeks

    Long-term users often describe a stable, familiar response with each infusion cycle.

  6. 6

    16–20 Weeks

    Effects generally remain tied to the frequency of infusions rather than building cumulatively.

  7. 7

    21–24 Weeks

    By this stage, most users have an established personal sense of how long benefits last between sessions.

⚠️ Research context only. This is not medical advice and results are not guaranteed.